EP300 and neoplasm: These results suggest that MmuPV1 E6 does not modulate EP300 activities as has been reported for HPV8 E6 [17, 38, 39] but that MmuPV1 and HPV8 E6 share the capacity to associate with components of the NOTCH and TGF-β tumor suppressor pathways.